OpenAI GPT 5 Meets Meta’s AI Labs
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
OpenAI GPT 5 Meets Meta’s AI Labs
-
ナレーター：
-
著者：
このコンテンツについて
In this episode, we discuss OpenAI’s GPT 5, Meta’s Superintelligence Labs investment, and Isomorphic Labs’ AI-driven drug discovery. OpenAI’s GPT 5 sets new benchmarks in multimodal reasoning, real-time web search, and accuracy improvements while Meta’s $14.3 billion bet on Scale AI and talent recruitment underscores its AI ambitions. We also explore Isomorphic Labs’ AlphaFold 3 platform and partnerships with Novartis and Eli Lilly to accelerate AI-driven drug discovery for cancer and immune diseases. Tune in for a deep dive into the AI breakthroughs reshaping technology and healthcare.
Help support the podcast by using our affiliate links: Eleven Labs: https://try.elevenlabs.io/ibl30sgkibkv
Disclaimer
This podcast is an independent production and is not affiliated with, endorsed by, or sponsored by OpenAI, Meta, Scale AI, Isomorphic Labs, Google DeepMind, Novartis, Eli Lilly, or any other entities mentioned unless explicitly stated. The content is for educational and entertainment purposes only and does not constitute professional, financial, or medical advice. Affiliate links help support the show at no extra cost to you."